CDC Changes COVID Policy

MicrobeTV

P. Offit, V. Racaniello

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

What's New with COVID in 2024?

Michigan Medicine

L. Washer

Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

Project 2025 vs. the Public's Health Part III: The NIH

MicrobeTV

P. Offit, V. Racaniello

Vaccination vs. Antiviral Therapy Against Mpox, Authorization and Ap…

MicrobeTV

D. Griffin, V. Racaniello

Current Controversies in Long Covid: The Relationships Among Long CO…

Leonard Calabrese

What to Know About New JN.1 COVID-19 Variant?

Amesh Adalja

Recent ACIP Recommendations for RSV Vaccines for Patients Over 60, T…

MicrobeTV

D. Griffin, V. Racaniello

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

The Crisis of Lung Health: The Achilles’ Heel We Didn’t Know We Had

University of Colorado Department of Medicine

M. Han

COVID-19 Updates (2024): Seroprevalence, Vaccination, and Therapeuti…

McMaster University Department of Medicine

Z. Chagla

Does Everyone Need a Yearly COVID Booster?

MicrobeTV

P. Offit, V. Racaniello

IDSA Guidelines for Using Anti-SARS-CoV-2 Monoclonal Antibody Therap…

MicrobeTV

D. Griffin, V. Racaniello

Mpox Circulation and New Vaccine Approval, Largest Outbreak of Whoop…

MicrobeTV

D. Griffin, V. Racaniello

Three Years of COVID-19: How Has Our Knowledge and Understanding of …

McMaster University Department of Medicine

D. Mertz

How Will New Variants Impact Updated COVID-19 Vaccines?

David Montefiori

New COVID 19 Variant: Arcturus (Omicron XBB.1.16) Increasing. What's…

MedCram

R. Seheult

Update on Long COVID

UCSF School of Medicine

R. Wachter, Z. Al-Aly, A. Iwasaki, M. Peluso

Advances in Immunology for the Non-Immunologist: The Human Immune Re…

Cleveland Clinic Rheumatology

L. Calabrese